Olivier Ormezzano

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Martine Gilard, Paul Barragan, Arif A.L. Noryani et al. · Journal of the American College of Cardiology · 2014 · 348 citations

Thrombosis, Endovascular Technique, Cardiovascular Disease +10

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Long-Term Additive Prognostic Value of Thallium-201 Myocardial Perfusion Imaging Over Clinical and Exercise Stress Test in Low to Intermediate Risk Patients

Gérald Vanzetto, Olivier Ormezzano, Daniel Fagret et al. · Circulation · 1999 · 195 citations

Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients

Jean-Philippe Baguet, Laure Hammer, Patrick Lévy et al. · Journal of Hypertension · 2005 · 194 citations

High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia

Pierre‐François Plouin, Jean-Philippe Baguet, F. Thony et al. · Hypertension · 2017 · 154 citations · Full text